Foreword
A worldwide profile of the utilization of sperm DNA fragmentation testing in relation to reproductive outcome
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S320-S321
.
(30 September 2017)
Clinical utility of sperm DNA fragmentation testing: practice recommendations based on clinical scenarios
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S322-S323
.
(30 September 2017)
Everything you always wanted to know about sperm DNA fragmentation testing
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S324-S325
.
(30 September 2017)
The benefits and limitations of sperm DNA testing in clinical practice
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S326-S327
.
(30 September 2017)
Evidence-based application of sperm DNA fragmentation testing
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S328
.
(30 September 2017)
Sperm DNA integrity testing—a valuable clinical tool
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S329-S330
.
(30 September 2017)
Sperm DNA fragmentation testing is the way forward
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S331
.
(30 September 2017)
Sperm DNA fragmentation testing: an evolving frontier
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S332-S333
.
(30 September 2017)
DNA fragmentation: a skeptic sees a bright future
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S334
.
(30 September 2017)
Sperm DNA fragmentation testing
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S335-S336
.
(30 September 2017)
Sperm DNA fragmentation
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S337-S338
.
(30 September 2017)
Sperm DNA fragmentation testing: a standard semen test or not ready for prime time?
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S339-S340
.
(30 September 2017)
Sperm DNA integrity: from ‘promising’ to standardization
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S341-S342
.
(30 September 2017)
Editorial
Frontiers in clinical andrology
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S343-S345
.
(30 September 2017)
Meet Guest Editor
Meet Guest Editor
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S346-S349
.
(30 September 2017)
Meet the Contributors
Meet the Contributors
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S350-S365
.
(30 September 2017)
Clinical Guideline Concise
Clinical utility of sperm DNA fragmentation testing: concise practice recommendations
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S366-S373
.
(30 September 2017)
Commentary
Commentary on clinical utility of sperm DNA fragmentation testing
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S374-S376
.
(30 September 2017)
Editorial
Despite limitations, sperm DNA fragmentation testing provides unique information complementary to but distinct from semen analysis results
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S377-S378
.
(30 September 2017)
Commentary
Finding the fit: sperm DNA integrity testing for male infertility
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S379-S380
.
(30 September 2017)
Editorial
More good than harm should be expected when Testi-ICSI is applied to oligozoospermic men with post-testicular sperm DNA fragmentation
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S381-S384
.
(30 September 2017)
Commentary
Sperm DNA fragmentation testing: ready for prime time?
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S385-S388
.
(30 September 2017)
Editorial
Sperm DNA fragmentation testing is on the right track
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S389-S391
.
(30 September 2017)
Commentary
Sperm DNA fragmentation: indication and uses
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S392-S393
.
(30 September 2017)
Editorial
Sperm DNA fragmentation: a key player in decision making
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S394-S396
.
(30 September 2017)
Commentary
Practical applications of sperm DNA fragmentation testing and its role in infertility
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S397-S398
.
(30 September 2017)
Editorial
Call for wider application of sperm DNA fragmentation test
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S399-S401
.
(30 September 2017)
Commentary
Implications of ejaculatory sperm DNA fragmentation on male infertility management
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S402-S404
.
(30 September 2017)
Editorial
Sperm DNA fragmentation for the evaluation of male infertility: clinical algorithms
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S405-S408
.
(30 September 2017)
Commentary
Sperm DNA fragmentation: the evolution of guidelines for patient testing and management
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S409-S411
.
(30 September 2017)
Editorial
The problem of mixing ‘apples and oranges’ in meta-analytic studies
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S412-S413
.
(30 September 2017)
Commentary
A guide to sperm DNA fragmentation testing
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S414-S415
.
(30 September 2017)
Editorial
The value of sperm DNA fragmentation testing in real-life clinical presentations
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S416-S418
.
(30 September 2017)
Commentary
Is sperm DNA fragmentation testing ready for prime time?
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S419-S421
.
(30 September 2017)
Editorial
Sperm DNA fragmentation: overcoming standardization obstacles
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S422-S424
.
(30 September 2017)
Commentary
Sperm DNA fragmentation testing: proceed with care
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S425-S427
.
(30 September 2017)
Editorial
Further evidence supports the clinical utility of sperm DNA fragmentation testing in male infertility workup and assisted reproductive technology
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S428-S436
.
(30 September 2017)
Commentary
Is testing of sperm DNA fragmentation (SDF) ready for the basic work-up of male infertility?
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S437-S439
.
(30 September 2017)
Editorial
Expanding our understanding of clinical laboratory testing in male infertility patients
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S440-S442
.
(30 September 2017)
Commentary
Using sperm testing to improve patient and offspring health: rational, evidence-based care of the infertile male in the ART clinic
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S443-S445
.
(30 September 2017)
Editorial
Sperm DNA fragmentation testing is the safe and economical way to go
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S446-S447
.
(30 September 2017)
Commentary
The role for sperm DNA damage testing in 2017
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S448-S449
.
(30 September 2017)
Editorial
Expanding treatment paradigm of high sperm DNA fragmentation
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S450-S452
.
(30 September 2017)
Commentary
Pros and cons of sperm DNA fragmentation testing: weighing the evidence
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S453-S454
.
(30 September 2017)
Editorial
Sperm DNA fragmentation: a rationale for its clinical utility
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S455-S456
.
(30 September 2017)
Commentary
Frontiers in sperm function testing: DNA fragmentation analysis shows promise
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S457-S458
.
(30 September 2017)
Editorial
Sperm DNA fragmentation testing in patients with subclinical varicocele: is there any evidence?
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S459-S461
.
(30 September 2017)
Commentary
Utility of testing sperm DNA fragmentation: an all-in-one diagnostic tool to address a multi-pronged clinical problem
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S462-S464
.
(30 September 2017)
Editorial
All-round approach in diagnosis
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S465-S467
.
(30 September 2017)
Commentary
Eight tests for sperm DNA fragmentation and their roles in the clinic
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S468-S470
.
(30 September 2017)
Editorial
From bench to clinic
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S471-S472
.
(30 September 2017)
Commentary
A few more fragments: putting sperm DNA integrity testing into clinical practice
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S473-S475
.
(30 September 2017)
Editorial
Development of treatment strategies in men with vulnerable sperm
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S476-S478
.
(30 September 2017)
Commentary
Practical considerations for DNA fragmentation testing in the management of male fertility
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S479-S480
.
(30 September 2017)
Editorial
The missing piece in management of infertile couple—clinical andrology
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S481-S483
.
(30 September 2017)
Commentary
Clinical usefulness of sperm DNA fragmentation testing
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S484-S487
.
(30 September 2017)
Editorial
The role of female factors in the management of sperm DNA fragmentation
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S488-S490
.
(30 September 2017)
Commentary
The quest of finding the perfect spermatozoon
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S491-S492
.
(30 September 2017)
Editorial
Restoration of fertility potential via targeted treatment approach
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S493-S494
.
(30 September 2017)
Commentary
Evaluation of sperm chromatin structure and DNA strand breaks is an important part of clinical male fertility assessment
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S495-S500
.
(30 September 2017)
Editorial
A single cut-off value of SDF testing does not fit all
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S501-S503
.
(30 September 2017)
Commentary
Sperm DNA fragmentation testing: when and why?
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S504-S505
.
(30 September 2017)
Editorial
Unraveling the utility and limitations of clinical practice guidelines
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S506-S508
.
(30 September 2017)
Commentary
Utility of sperm DNA fragmentation testing in different clinical scenarios of male reproductive abnormalities and its influence in natural and assisted reproduction
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S509-S512
.
(30 September 2017)
Editorial
Sperm DNA fragmentation testing reveals the overall quality of a semen sample
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S513-S515
.
(30 September 2017)
Commentary
Sperm DNA fragmentation
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S516-S518
.
(30 September 2017)
Editorial
Risk factors associated with sperm DNA fragmentation
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S519-S521
.
(30 September 2017)
Commentary
Commentary on sperm DNA fragmentation testing clinical guideline
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S522-S524
.
(30 September 2017)
Editorial
Future direction in sperm DNA fragmentation testing
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S525-S526
.
(30 September 2017)
Commentary
Evidence based sperm DNA fragmentation
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S527-S528
.
(30 September 2017)
Editorial
Drawbacks of the current practice
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S529-S531
.
(30 September 2017)
Commentary
Clinical utility of sperm DNA fragmentation testing: article overview
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S532-S534
.
(30 September 2017)
Editorial
Understanding sperm DNA fragmentation
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S535-S538
.
(30 September 2017)
Commentary
DNA fragmentation and the ultimate success of a pregnancy
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S539-S543
.
(30 September 2017)
Editorial
Sperm DNA fragmentation in clinical practice
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S544-S546
.
(30 September 2017)
Commentary
Clinical use of sperm DNA fragmentation analysis results, a practical example of how to deal with too much information from the literature in reproductive medicine
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S547-S548
.
(30 September 2017)
Editorial
Current limitation and future perspective of sperm DNA fragmentation tests
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S549-S552
.
(30 September 2017)
Commentary
Evaluation of sperm DNA structure, fragmentation and decondensation: an essential tool in the assessment of male infertility
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S553-S556
.
(30 September 2017)
Editorial
The complex nature of the sperm DNA damage process
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S557-S559
.
(30 September 2017)
Commentary
Some relevant points on sperm DNA fragmentation tests
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S560-S563
.
(30 September 2017)
Editorial
Live birth must be the primary reproductive endpoint in IVF/ICSI studies evaluating sperm DNA fragmentation testing
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S564-S565
.
(30 September 2017)
Commentary
Clinical scenarios of unexplained sperm DNA fragmentation and their management
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S566-S569
.
(30 September 2017)
Editorial
Comparison of strategies to reduce sperm DNA fragmentation in couples undergoing ICSI
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S570-S573
.
(30 September 2017)
Commentary
Clinical utility of sperm DNA fragmentation testing: practice recommendations based on clinical scenarios
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S574-S576
.
(30 September 2017)
Editorial
It is high time for clinical application of sperm DNA fragmentation testing
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S577-S579
.
(30 September 2017)
Commentary
Sperm DNA fragmentation testing in male infertility work-up: are we ready?
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S580-S582
.
(30 September 2017)
Editorial
Implication of sperm processing during assisted reproduction on sperm DNA integrity
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S583-S585
.
(30 September 2017)
Commentary
Guidelines on sperm DNA fragmentation testing
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S586-S587
.
(30 September 2017)
Commentary
Measure of sperm DNA fragmentation (SDF): how, why and when?
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S588-S589
.
(30 September 2017)
Commentary
Sperm DNA integrity testing: a valuable addition to the tool box of infertility clinicians
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S590-S591
.
(30 September 2017)
Editorial
Sperm DNA fragmentation test results reflect the overall quality of the whole semen specimen
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S592-S593
.
(30 September 2017)
Commentary
Is the sperm DNA status the best predictor of both natural and assisted conception?
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S594-S596
.
(30 September 2017)
Editorial
The price and value of sperm DNA fragmentation tests
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S597-S599
.
(30 September 2017)
Commentary
The role of sperm DNA testing on male infertility
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S600-S603
.
(30 September 2017)
Editorial
The importance of quality control and quality assurance in SDF testing
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S604-S606
.
(30 September 2017)
Commentary
Testing of sperm DNA damage and clinical recommendations
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S607-S609
.
(30 September 2017)
Editorial
Development of targeted therapeutic strategies and refinement of sperm DNA fragmentation testing
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S610-S612
.
(30 September 2017)
Commentary
Application of sperm DNA fragmentation test in clinical setting
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S613-S614
.
(30 September 2017)
Editorial
Is National Institute of Clinical Excellence (NICE) guideline a nice guideline?
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S615-S617
.
(30 September 2017)
Commentary
Sperm DNA fragmentation testing as a diagnostic and prognostic parameter of couple infertility
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S618-S620
.
(30 September 2017)
Editorial
The correct interpretation of sperm DNA fragmentation test
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S621-S623
.
(30 September 2017)
Commentary
Assessing the male in fertility clinics—men undervalued, undermanaged and undertreated
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S624-S628
.
(30 September 2017)
Editorial
Integrating surgical and clinical andrology is essential to improve the quality of care delivered to infertile couples
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S629-S631
.
(30 September 2017)
Commentary
Clinical utility of sperm DNA fragmentation testing: a commentary
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S632-S635
.
(30 September 2017)
Editorial
Technical aspects of sperm DNA fragmentation testing, methods to select sperm with low DNA fragmentation, and usefulness of redox potential measurement in male infertility
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S636-S639
.
(30 September 2017)
Commentary
Routine assessment of sperm DNA fragmentation in clinical practice: commentary and perspective
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S640-S643
.
(30 September 2017)
Editorial
Insights on the predictive accuracy of the sperm DNA fragmentation tests on male infertility
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S644-S646
.
(30 September 2017)
Commentary
Commentary: sperm DNA fragmentation testing in action
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S647-S648
.
(30 September 2017)
Editorial
Antioxidants for elevated sperm DNA fragmentation: a mini review
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S649-S653
.
(30 September 2017)
Commentary
Sperm DNA fragmentation testing—clinical utility
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S654-S655
.
(30 September 2017)
Commentary
Clinical implication of DNA fragmentation in male infertility
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S656-S657
.
(30 September 2017)
Editorial
Elucidating the clinical indications of sperm DNA fragmentation in male infertility
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S658-S660
.
(30 September 2017)
Commentary
A perspective on sperm DNA fragmentation
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S661-S664
.
(30 September 2017)
Editorial
An evidence-based perspective on the role of sperm chromatin integrity and sperm DNA fragmentation testing in male infertility
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S665-S672
.
(30 September 2017)
Commentary
Use of sperm DNA fragmentation test in ART setting: is it a promising diagnostic test?
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S673-S674
.
(30 September 2017)
Editorial
Sperm DNA fragmentation: laboratory and clinical aspects
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S675-S677
.
(30 September 2017)
Commentary
Commentary: the value of testing sperm DNA fragmentation in infertile men
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S678-S680
.
(30 September 2017)
Commentary
Recognizing sperm DNA fragmentation testing in clinical evaluation of male fertility
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S681-S682
.
(30 September 2017)
Editorial
Best practice statements are not intended to dictate an exclusive course of management
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S683-S684
.
(30 September 2017)
Commentary
Clinical utility of sperm DNA fragmentation testing: a requisite to infertility practice
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S685-S687
.
(30 September 2017)
Editorial
Use of sperm DNA fragmentation testing and testicular sperm for intracytoplasmic sperm injection
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S688-S690
.
(30 September 2017)
Commentary
Sperm DNA damage diagnostics: when and why
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S691-S694
.
(30 September 2017)
Editorial
Reactive oxygen species and sperm DNA fragmentation
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S695-S696
.
(30 September 2017)
Commentary
Sperm DNA fragmentation testing: where we stand in 2017
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S697-S698
.
(30 September 2017)
Commentary
Should sperm DNA fragmentation testing be routinely used in assessing male infertility?
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S699-S701
.
(30 September 2017)
Editorial
The debate on sperm DNA fragmentation test goes on
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S702-S703
.
(30 September 2017)
Commentary
Infertility, recurrent pregnancy loss and sperm DNA fragmentation, have we found the missing link?
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S704-S706
.
(30 September 2017)
Editorial
One of the many missing links between infertility and sperm DNA fragmentation
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S707-S709
.
(30 September 2017)
Original Article
Sperm DNA fragmentation testing: a cross sectional survey on current practices of fertility specialists
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S710-S719
.
(30 September 2017)
Guideline
The Society for Translational Medicine: clinical practice guidelines for sperm DNA fragmentation testing in male infertility
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S720-S733
.
(30 September 2017)
Original Article
A Strengths-Weaknesses-Opportunities-Threats (SWOT) analysis on the clinical utility of sperm DNA fragmentation testing in specific male infertility scenarios
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S734-S760
.
(30 September 2017)
Perspective
DNA damage in human spermatozoa; important contributor to mutagenesis in the offspring
Translational Andrology and Urology
2017;
6
(Suppl 4)
:S761-S764
.
(30 September 2017)
Disclosure:
The supplement “Sperm DNA Fragmentation” was commissioned by the editorial office, Translational Andrology and Urology without any sponsorship or funding. Ashok Agarwal, Ahmad Majzoub, Sandro C. Esteves and Chak-Lam Cho served as the unpaid Guest Editors for the supplement.
